DexCom Aktie

73,08USD 0,82USD 1,13%
DexCom für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: A0D9T1 / ISIN: US2521311074

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 6 300 7 600 9 600 10 300 11 100
Umsatz pro Mitarbeiter in Mio. EUR 0,39 0,38 0,38 0,39 0,42

Bilanz (in Mio. USD) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 3 684 3 669 4 426 4 301 4 033
Summe Anlagevermögen 1 179 1 723 1 839 2 183 2 307
Summe Aktiva 4 864 5 392 6 265 6 485 6 340

Bilanz (in Mio. USD) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 2 612 3 260 4 196 4 382 3 594
Summe Eigenkapital 2 252 2 132 2 069 2 103 2 746
Summe Passiva 4 864 5 392 6 265 6 485 6 340

Adresse

6340 Sequence Drive, 92121 San Diego
Telefon +1 (858) 200-0200
Internet http://www.dexcom.com

Management

Bridgette P. Heller
Independent Director
Donald M. Abbey
Executive VP-Regulatory, Medical & Clinal Affairs
Euan A. Ashley
Independent Director
Girish Naganathan
Chief Technology Officer & Executive VP
Jacob S. Leach
President, Chief Executive Officer & Director
Jereme M Sylvain
Chief Financial Officer & Executive Vice President
Jon Curtis Coleman
Chief Commercial Officer & Executive VP
Kevin Ronald Sayer
Executive Chairman
Kyle J. Malady
Independent Director
Mark G. Foletta
Lead Independent Director
Matt V. Dolan
Executive VP-Strategy & Corporate Development
Matthew Joseph Carey
Senior Manager-Investor Relations
Michael Jon Brown
Chief Legal Officer & Executive Vice President
Nicholas Augustinos
Independent Director
Renée D. Galá
Independent Director
Richard Alexander Collins
Independent Director
Rimma Driscoll
Independent Director
Sadie M Stern
Chief Human Resources Officer & Executive VP
Sean Christensen
Vice President-Finance & Investor Relations
Stacey Stewart
Chief Information Officer & Senior Vice President
Steven R. Altman
Independent Director